Value for Money in Donor HIV Funding

Sebastian Linnemayr, Gery W. Ryan, Jenny Liu, Kartika Palar

ResearchPublished Oct 6, 2011

Cover: Value for Money in Donor HIV Funding

Countries with the highest burden of human immunodeficiency virus (HIV) disease are heavily reliant on donor funding from such sources as the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria for their HIV programs. In recent years, commitments from these organizations have flattened while demand for HIV/AIDS care continues to rise. To meet the continued need for more HIV services in developing countries, existing resources need to be better leveraged, i.e., to provide improved value for the money. This report examines options for improving value for money in HIV funding by using a case study that focuses on the two largest funders, PEPFAR and the Global Fund, with funding for antiretroviral therapy (ART) as its leading example. The authors' assessment of available input and output data suggests that current spending allocations across direct and indirect services are not based on increasing value for money. The authors recommend that expenditure data for PEPFAR be made available to the public in a transparent fashion on an annual basis in a usable format and that the Global Fund make its data accessible for each program funded. They find that program output indicators to track indirect services are incomplete and need to be further developed. The trade-off between providing current services and providing future ones needs to be stated clearly, and funding decisions made accordingly. Finally, given projections that funding for HIV will likely not increase, particularly for low-income countries facing the highest HIV burden, an explicit emphasis on improving value for money by finding ways to better leverage existing monies is imperative.

Topics

Document Details

  • Availability: Web-Only
  • Year: 2011
  • Pages: 92
  • Document Number: TR-1158-AHF

Citation

RAND Style Manual
Linnemayr, Sebastian, Gery W. Ryan, Jenny Liu, and Kartika Palar, Value for Money in Donor HIV Funding, RAND Corporation, TR-1158-AHF, 2011. As of October 4, 2024: https://www.rand.org/pubs/technical_reports/TR1158.html
Chicago Manual of Style
Linnemayr, Sebastian, Gery W. Ryan, Jenny Liu, and Kartika Palar, Value for Money in Donor HIV Funding. Santa Monica, CA: RAND Corporation, 2011. https://www.rand.org/pubs/technical_reports/TR1158.html.
BibTeX RIS

This work was prepared for the AIDS Healthcare Foundation. The research was conducted in RAND Health, a unit of the RAND Corporation.

This publication is part of the RAND technical report series. RAND technical reports, products of RAND from 2003 to 2011, presented research findings on a topic limited in scope or intended for a narrow audience; discussions of the methodology employed in research; literature reviews, survey instruments, modeling exercises, guidelines for practitioners and research professionals, and supporting documentation; and preliminary findings. All RAND technical reports were subject to rigorous peer review to ensure high standards for research quality and objectivity.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.